Credit Suisse’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

Credit Suisse’s Portfolio RPTP Stock Details RPTP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-5,702,042	Closed	-$29.6M	–	4569
2015 Q4	$29.6M	Sell	5,702,042 -76,627	-1%	-$445K	0.03%	592
2015 Q3	$35M	Buy	5,778,669 +91,243	+2%	+$1.12M	0.04%	498
2015 Q2	$89.8M	Buy	5,687,426 +426,574	+8%	+$5.18M	0.09%	240
2015 Q1	$57.2M	Sell	5,260,852 -695,297	-12%	-$7.1M	0.06%	368
2014 Q4	$62.7M	Buy	5,956,149 +718,277	+14%	+$7.02M	0.06%	372
2014 Q3	$50.2M	Buy	5,237,872 +775,661	+17%	+$7.92M	0.04%	504
2014 Q2	$51.5M	Buy	4,462,211 +137,618	+3%	+$1.25M	0.04%	467
2014 Q1	$43.2M	Sell	4,324,593 -966,007	-18%	-$13.9M	0.04%	475
2013 Q4	$68.9M	Buy	5,290,600 +210,714	+4%	+$2.9M	0.06%	300
2013 Q3	$75.8M	Buy	5,079,886 +1,266,537	+33%	+$15.2M	0.08%	238
2013 Q2	$35.7M	Buy	+3,813,349	New	+$25.8M	0.04%	493

Other funds holding RPTP

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Credit Suisse's RPTP Position: Q1 2016 in Review

Credit Suisse sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q1 2016, closing a stake of 5,702,042 shares — an estimated $29.6M sold.

Credit Suisse first reported a position in RPTP in Q2 2013 and held it in 11 quarters. The position peaked at $89.8M in Q2 2015. 97 funds tracked by Wall St. Rank hold RPTP as of Q1 2016.

Credit Suisse reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q1 2016 after selling out during the quarter.
Credit Suisse sold 5,702,042 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q1 2016, an estimated $29.6M.
Credit Suisse first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q2 2013 and held it in 11 quarters.
Credit Suisse's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $89.8M in Q2 2015.
97 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q1 2016.

Based on Credit Suisse's 13F filing for Q1 2016, filed 16 May 2016.